Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969384499> ?p ?o ?g. }
- W2969384499 abstract "Abstract Introduction An age‐specific evaluation and management algorithm for reduced bone mineral density ( BMD ) is suggested for HIV‐positive patients without major risk factors. Whether combination of BMD and the Fracture Risk Assessment Tool ( FRAX ) may detect more individuals for therapeutic interventions remains unclear. We aimed to determine the prevalence of middle‐aged or older HIV‐positive males fitting the criteria of therapeutic interventions with different approaches. Methods From July 2016 to February 2018, HIV‐positive male patients aged ≥45 years receiving suppressive antiretroviral therapy were recruited in a cross‐sectional study, at two designated hospitals for HIV care in northern Taiwan. Patients with malignancy, AIDS , pre‐existing bone disease or immobilization were excluded. Information on clinical and demographic characteristics, FRAX questionnaire, activity questionnaire, BMD and serum 25( OH )D was obtained. FRAX scores combined with BMD ( FRAX / BMD ) and without BMD ( FRAX ) were calculated. The data were analysed on the basis of major risk factors for fragility fracture and age stratification, FRAX score and BMD results respectively. Results We enrolled 330 patients with a mean age of 51.6 years and CD 4 610 cells/μL, in whom 98.1% (n = 324) underwent BMD assessment of one site or more. By FRAX , 6.7% (n = 22) reached treatment thresholds (10‐year risk of major osteoporotic fracture ≥20% and/or hip fracture ≥3%). The prevalence of osteopenia (−2.5 <T‐score <−1) and osteoporosis (T‐score ≤−2.5) was 50.3% and 10.8% respectively. Compared with FRAX , FRAX / BMD identified 17.4% (95% CI 12.0% to 22.8%) more individuals who reached treatment thresholds (24.1% vs. 6.7%); even in the low‐risk group (without major risks for fragility fracture, 45 to 49 years, n = 129), FRAX / BMD identified 12.6% (95% CI 7.9% to 19.7%) more candidates (12.6% vs. 0%). Patients with BMI <22 kg/m 2 (adjusted OR ( aOR ) 2.86, 95% CI 1.62 to 5.05) and aged ≥50 years ( aOR 3.57, 95% CI 1.92 to 6.66) were more likely not to be identified as requiring treatment by FRAX but would be identified as requiring treatment by FRAX / BMD . The sensitivity and specificity of FRAX to detect candidates for interventions was 18.2% (95% CI 10.3% to 28.6%) and 97.9% (95% CI 95.2% to 99.3%) respectively. Conclusions With FRAX as a screening approach among HIV‐positive male patients aged ≥45 years, addition of BMD assessment may detect more candidates for therapeutic management." @default.
- W2969384499 created "2019-08-29" @default.
- W2969384499 creator A5018747786 @default.
- W2969384499 creator A5045726251 @default.
- W2969384499 creator A5051731266 @default.
- W2969384499 creator A5054470933 @default.
- W2969384499 creator A5056104951 @default.
- W2969384499 creator A5072183192 @default.
- W2969384499 creator A5078113145 @default.
- W2969384499 date "2019-08-01" @default.
- W2969384499 modified "2023-10-14" @default.
- W2969384499 title "Performance of fracture risk assessment tool in HIV ‐positive male individuals aged ≥45 years on suppressive antiretroviral therapy" @default.
- W2969384499 cites W1544458643 @default.
- W2969384499 cites W1940034849 @default.
- W2969384499 cites W1985255191 @default.
- W2969384499 cites W1986700262 @default.
- W2969384499 cites W1994509717 @default.
- W2969384499 cites W2006498349 @default.
- W2969384499 cites W2010871211 @default.
- W2969384499 cites W2025740330 @default.
- W2969384499 cites W2057060681 @default.
- W2969384499 cites W2061555322 @default.
- W2969384499 cites W2068947159 @default.
- W2969384499 cites W2090125257 @default.
- W2969384499 cites W2107789045 @default.
- W2969384499 cites W2112636117 @default.
- W2969384499 cites W2118188765 @default.
- W2969384499 cites W2144658061 @default.
- W2969384499 cites W2151771709 @default.
- W2969384499 cites W2152105296 @default.
- W2969384499 cites W2169183011 @default.
- W2969384499 cites W2171129594 @default.
- W2969384499 cites W2310137409 @default.
- W2969384499 cites W2407228456 @default.
- W2969384499 cites W2411796698 @default.
- W2969384499 cites W2589178796 @default.
- W2969384499 cites W2593561975 @default.
- W2969384499 cites W2736419155 @default.
- W2969384499 cites W2737085999 @default.
- W2969384499 cites W2800467530 @default.
- W2969384499 cites W2804582715 @default.
- W2969384499 cites W2895727744 @default.
- W2969384499 cites W2906318256 @default.
- W2969384499 cites W2916304357 @default.
- W2969384499 cites W2941952146 @default.
- W2969384499 cites W2946496187 @default.
- W2969384499 cites W2947945912 @default.
- W2969384499 cites W2969384499 @default.
- W2969384499 cites W99395736 @default.
- W2969384499 doi "https://doi.org/10.1002/jia2.25383" @default.
- W2969384499 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6698691" @default.
- W2969384499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31423752" @default.
- W2969384499 hasPublicationYear "2019" @default.
- W2969384499 type Work @default.
- W2969384499 sameAs 2969384499 @default.
- W2969384499 citedByCount "1" @default.
- W2969384499 countsByYear W29693844992022 @default.
- W2969384499 crossrefType "journal-article" @default.
- W2969384499 hasAuthorship W2969384499A5018747786 @default.
- W2969384499 hasAuthorship W2969384499A5045726251 @default.
- W2969384499 hasAuthorship W2969384499A5051731266 @default.
- W2969384499 hasAuthorship W2969384499A5054470933 @default.
- W2969384499 hasAuthorship W2969384499A5056104951 @default.
- W2969384499 hasAuthorship W2969384499A5072183192 @default.
- W2969384499 hasAuthorship W2969384499A5078113145 @default.
- W2969384499 hasBestOaLocation W29693844991 @default.
- W2969384499 hasConcept C118552586 @default.
- W2969384499 hasConcept C126322002 @default.
- W2969384499 hasConcept C1862650 @default.
- W2969384499 hasConcept C27415008 @default.
- W2969384499 hasConcept C2776541429 @default.
- W2969384499 hasConcept C2776886416 @default.
- W2969384499 hasConcept C2777083390 @default.
- W2969384499 hasConcept C2777525943 @default.
- W2969384499 hasConcept C2994343686 @default.
- W2969384499 hasConcept C71924100 @default.
- W2969384499 hasConceptScore W2969384499C118552586 @default.
- W2969384499 hasConceptScore W2969384499C126322002 @default.
- W2969384499 hasConceptScore W2969384499C1862650 @default.
- W2969384499 hasConceptScore W2969384499C27415008 @default.
- W2969384499 hasConceptScore W2969384499C2776541429 @default.
- W2969384499 hasConceptScore W2969384499C2776886416 @default.
- W2969384499 hasConceptScore W2969384499C2777083390 @default.
- W2969384499 hasConceptScore W2969384499C2777525943 @default.
- W2969384499 hasConceptScore W2969384499C2994343686 @default.
- W2969384499 hasConceptScore W2969384499C71924100 @default.
- W2969384499 hasFunder F4320323468 @default.
- W2969384499 hasIssue "8" @default.
- W2969384499 hasLocation W29693844991 @default.
- W2969384499 hasLocation W29693844992 @default.
- W2969384499 hasLocation W29693844993 @default.
- W2969384499 hasLocation W29693844994 @default.
- W2969384499 hasOpenAccess W2969384499 @default.
- W2969384499 hasPrimaryLocation W29693844991 @default.
- W2969384499 hasRelatedWork W144146190 @default.
- W2969384499 hasRelatedWork W1760222648 @default.
- W2969384499 hasRelatedWork W1973970721 @default.
- W2969384499 hasRelatedWork W2060089816 @default.
- W2969384499 hasRelatedWork W2332517211 @default.
- W2969384499 hasRelatedWork W2620216110 @default.